{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T09:22:49Z","timestamp":1770715369369,"version":"3.49.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"name":"ANRF- SERB POWER","award":["SPG\/2021\/002524"],"award-info":[{"award-number":["SPG\/2021\/002524"]}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["BT\/RLF\/Re-entry\/58\/2017"],"award-info":[{"award-number":["BT\/RLF\/Re-entry\/58\/2017"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"DOI":"10.1186\/s10020-025-01417-w","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T01:15:54Z","timestamp":1768266954000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hepatic loss of AATF attenuates MASH by suppressing AKT\u2013mTORC1 signaling and reprogramming lipid metabolism"],"prefix":"10.1186","volume":"32","author":[{"given":"Akshatha N.","family":"Srinivas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diwakar","family":"Suresh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prajna","family":"Anirvan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manju","family":"Moorthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gopalkrishna","family":"Ramaswamy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suma M.","family":"Nataraj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prasanna Kumar","family":"Santhekadur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepak","family":"Suvarna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shivaram P.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Divya P.","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,13]]},"reference":[{"issue":"8","key":"1417_CR1","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.202003131","volume":"219","author":"MG Acoba","year":"2020","unstructured":"Acoba MG, Senoo N, Claypool SM. Phospholipid ebb and flow makes mitochondria go. J Cell Biol. 2020;219(8):e202003131. https:\/\/doi.org\/10.1083\/jcb.202003131.","journal-title":"J Cell Biol"},{"issue":"3","key":"1417_CR2","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1139\/apnm-2012-0261","volume":"38","author":"BM Arendt","year":"2013","unstructured":"Arendt BM, Ma DW, Simons B, Noureldin SA, Therapondos G, Guindi M, et al. Nonalcoholic fatty liver disease is associated with lower hepatic and erythrocyte ratios of phosphatidylcholine to phosphatidylethanolamine. Appl Physiol Nutr Metab. 2013;38(3):334\u201340. https:\/\/doi.org\/10.1139\/apnm-2012-0261.","journal-title":"Appl Physiol Nutr Metab"},{"issue":"3","key":"1417_CR3","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.jhep.2016.05.005","volume":"65","author":"A Asgharpour","year":"2016","unstructured":"Asgharpour A, Cazanave SC, Pacana T, Seneshaw M, Vincent R, Banini BA, et al. A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer. J Hepatol. 2016;65(3):579\u201388. https:\/\/doi.org\/10.1016\/j.jhep.2016.05.005.","journal-title":"J Hepatol"},{"key":"1417_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31609","author":"BA Banini","year":"2021","unstructured":"Banini BA, Kumar DP, Cazanave S, Seneshaw M, Mirshahi F, Santhekadur PK, et al. Identification of a metabolic, transcriptomic, and molecular signature of patatin-like phospholipase domain containing 3-mediated acceleration of steatohepatitis. Hepatology. 2021. https:\/\/doi.org\/10.1002\/hep.31609.","journal-title":"Hepatology"},{"issue":"2","key":"1417_CR5","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/hep.30418","volume":"70","author":"EM Brunt","year":"2019","unstructured":"Brunt EM, Kleiner DE, Wilson LA, Sanyal AJ, Neuschwander-Tetri BA, Nonalcoholic Steatohepatitis Clinical Research Network. Improvements in histologic features and diagnosis associated with improvement in fibrosis in nonalcoholic steatohepatitis: results from the Nonalcoholic Steatohepatitis Clinical Research Network treatment trials. Hepatology. 2019;70(2):522\u201331. https:\/\/doi.org\/10.1002\/hep.30418.","journal-title":"Hepatology"},{"issue":"1 Suppl","key":"1417_CR6","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","volume":"62","author":"CD Byrne","year":"2015","unstructured":"Byrne CD, Targher G. NAFLD: a multisystem disease. J Hepatol. 2015;62(1 Suppl):S47-64. https:\/\/doi.org\/10.1016\/j.jhep.2014.12.012.","journal-title":"J Hepatol"},{"issue":"6 Suppl","key":"1417_CR7","doi-asserted-by":"publisher","first-page":"1505S","DOI":"10.1093\/ajcn\/83.6.1505S","volume":"83","author":"PC Calder","year":"2006","unstructured":"Calder PC. N-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr. 2006;83(6 Suppl):1505S-1519S. https:\/\/doi.org\/10.1093\/ajcn\/83.6.1505S.","journal-title":"Am J Clin Nutr"},{"key":"1417_CR8","doi-asserted-by":"publisher","unstructured":"Candido CJ, Figueiredo PS, Del Ciampo Silva R, Portugal LC, Augusto Dos Santos Jaques J, Alves de Almeida J, et al. Protective Effect of \u03b1-Linolenic Acid on Non-Alcoholic Hepatic Steatosis and Interleukin-6 and -10 in Wistar Rats. Nutrients. 2019;12(1):9. https:\/\/doi.org\/10.3390\/nu12010009","DOI":"10.3390\/nu12010009"},{"issue":"12","key":"1417_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2024.101185","volume":"6","author":"F Carli","year":"2024","unstructured":"Carli F, Della Pepa G, Sabatini S, Vidal Puig A, Gastaldelli A. Lipid metabolism in MASLD and MASH: from mechanism to the clinic. JHEP Reports. 2024;6(12):101185. https:\/\/doi.org\/10.1016\/j.jhepr.2024.101185.","journal-title":"JHEP Reports"},{"issue":"4","key":"1417_CR10","doi-asserted-by":"publisher","first-page":"775","DOI":"10.2337\/db09-1602","volume":"59","author":"P Chakrabarti","year":"2010","unstructured":"Chakrabarti P, English T, Shi J, Smas CM, Kandror KV. Mammalian target of rapamycin complex 1 suppresses lipolysis, stimulates lipogenesis, and promotes fat storage. Diabetes. 2010;59(4):775\u201381. https:\/\/doi.org\/10.2337\/db09-1602.","journal-title":"Diabetes"},{"issue":"3","key":"1417_CR11","doi-asserted-by":"publisher","first-page":"197","DOI":"10.7570\/jomes23052","volume":"32","author":"WK Chan","year":"2023","unstructured":"Chan WK, Chuah KH, Rajaram RB, Lim LL, Ratnasingam J, Vethakkan SR. Metabolic dysfunction-associated steatotic liver disease (MASLD): a state-of-the-art review. J Obes Metab Syndr. 2023;32(3):197\u2013213. https:\/\/doi.org\/10.7570\/jomes23052.","journal-title":"J Obes Metab Syndr"},{"key":"1417_CR12","doi-asserted-by":"publisher","first-page":"46658","DOI":"10.1038\/srep46658","volume":"7","author":"F Chiappini","year":"2017","unstructured":"Chiappini F, Coilly A, Kadar H, Gual P, Tran A, Desterke C, et al. Metabolism dysregulation induces a specific lipid signature of nonalcoholic steatohepatitis in patients. Sci Rep. 2017;7:46658. https:\/\/doi.org\/10.1038\/srep46658.","journal-title":"Sci Rep"},{"key":"1417_CR13","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1097\/MOL.0b013e3282ffaf96","volume":"19","author":"JS Cohn","year":"2008","unstructured":"Cohn JS, Wat E, Kamili A, Tandy S. Dietary phospholipids, hepatic lipid metabolism and cardiovascular disease. Curr Opin Lipidol. 2008;19:257\u201362. https:\/\/doi.org\/10.1097\/MOL.0b013e3282ffaf96.","journal-title":"Curr Opin Lipidol"},{"issue":"5","key":"1417_CR14","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.3892\/ijmm.2016.2542","volume":"37","author":"J Cui","year":"2016","unstructured":"Cui J, Zhang F, Wang Y, Liu J, Ming X, Hou J, et al. Macrophage migration inhibitory factor promotes cardiac stem cell proliferation and endothelial differentiation through the activation of the PI3K\/Akt\/mTOR and AMPK pathways. Int J Mol Med. 2016;37(5):1299\u2013309. https:\/\/doi.org\/10.3892\/ijmm.2016.2542.","journal-title":"Int J Mol Med"},{"issue":"21","key":"1417_CR15","doi-asserted-by":"publisher","first-page":"5235","DOI":"10.12998\/wjcc.v8.i21.5235","volume":"8","author":"AI Dajani","year":"2020","unstructured":"Dajani AI, Popovic B. Essential phospholipids for nonalcoholic fatty liver disease associated with metabolic syndrome: a systematic review and network meta-analysis. World J Clin Cases. 2020;8(21):5235\u201349. https:\/\/doi.org\/10.12998\/wjcc.v8.i21.5235.","journal-title":"World J Clin Cases"},{"issue":"4","key":"1417_CR16","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1055\/a-2186-3557","volume":"43","author":"JL Dempsey","year":"2023","unstructured":"Dempsey JL, Ioannou GN, Carr RM. Mechanisms of lipid droplet accumulation in steatotic liver diseases. Semin Liver Dis. 2023;43(4):367\u201382. https:\/\/doi.org\/10.1055\/a-2186-3557.","journal-title":"Semin Liver Dis"},{"key":"1417_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.880298","volume":"13","author":"Y Duan","year":"2022","unstructured":"Duan Y, Pan X, Luo J, Xiao X, Li J, Bestman PL, et al. Association of inflammatory cytokines with non-alcoholic fatty liver disease. Front Immunol. 2022;13:880298. https:\/\/doi.org\/10.3389\/fimmu.2022.880298.","journal-title":"Front Immunol"},{"issue":"3","key":"1417_CR18","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","volume":"81","author":"European Association for the Study of the Liver (EASL)","year":"2024","unstructured":"European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), European Association for the Study of Obesity (EASO). EASL-EASD-EASO clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). J Hepatol. 2024;81(3):492\u2013542. https:\/\/doi.org\/10.1016\/j.jhep.2024.04.031.","journal-title":"J Hepatol"},{"issue":"1","key":"1417_CR19","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/ng1951","volume":"39","author":"J Fischer","year":"2007","unstructured":"Fischer J, Lef\u00e8vre C, Morava E, Mussini JM, Lafor\u00eat P, Negre-Salvayre A, et al. The gene encoding adipose triglyceride lipase (PNPLA2) is mutated in neutral lipid storage disease with myopathy. Nat Genet. 2007;39(1):28\u201330. https:\/\/doi.org\/10.1038\/ng1951.","journal-title":"Nat Genet"},{"issue":"1","key":"1417_CR20","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jhep.2022.02.003","volume":"77","author":"MF Fondevila","year":"2022","unstructured":"Fondevila MF, Fernandez U, Heras V, Parracho T, Gonzalez-Rellan MJ, Novoa E, et al. Inhibition of carnitine palmitoyltransferase 1A in hepatic stellate cells protects against fibrosis. J Hepatol. 2022;77(1):15\u201328. https:\/\/doi.org\/10.1016\/j.jhep.2022.02.003.","journal-title":"J Hepatol"},{"key":"1417_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2020.154186","volume":"105","author":"K Georgila","year":"2020","unstructured":"Georgila K, Gounis M, Havaki S, Gorgoulis VG, Eliopoulos AG. mTORC1-dependent protein synthesis and autophagy uncouple in the regulation of Apolipoprotein A-I expression. Metabolism. 2020;105:154186. https:\/\/doi.org\/10.1016\/j.metabol.2020.154186.","journal-title":"Metabolism"},{"issue":"6590","key":"1417_CR22","doi-asserted-by":"publisher","DOI":"10.1126\/science.abf8271","volume":"376","author":"BS Gosis","year":"2022","unstructured":"Gosis BS, Wada S, Thorsheim C, Li K, Jung S, Rhoades JH, et al. Inhibition of nonalcoholic fatty liver disease in mice by selective inhibition of mTORC1. Science. 2022;376(6590):eabf8271. https:\/\/doi.org\/10.1126\/science.abf8271.","journal-title":"Science"},{"key":"1417_CR23","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1038\/s42255-021-00493-6","volume":"3","author":"GF Grabner","year":"2021","unstructured":"Grabner GF, Xie H, Schweiger M, Zechner R. Lipolysis: cellular mechanisms for lipid mobilization from fat stores. Nat Metab. 2021;3:1445\u201365. https:\/\/doi.org\/10.1038\/s42255-021-00493-6.","journal-title":"Nat Metab"},{"key":"1417_CR24","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1186\/1471-2407-9-457","volume":"9","author":"M Haanp\u00e4\u00e4","year":"2009","unstructured":"Haanp\u00e4\u00e4 M, Reiman M, Nikkil\u00e4 J, Erkko H, Pylk\u00e4s K, Winqvist R. Mutation analysis of the AATF gene in breast cancer families. BMC Cancer. 2009;9:457. https:\/\/doi.org\/10.1186\/1471-2407-9-457.","journal-title":"BMC Cancer"},{"issue":"8","key":"1417_CR25","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1194\/jlr.R067595","volume":"57","author":"J Han","year":"2016","unstructured":"Han J, Kaufman RJ. The role of ER stress in lipid metabolism and lipotoxicity. J Lipid Res. 2016;57(8):1329\u201338. https:\/\/doi.org\/10.1194\/jlr.R067595.","journal-title":"J Lipid Res"},{"issue":"1","key":"1417_CR26","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.molcel.2020.05.007","volume":"79","author":"A He","year":"2020","unstructured":"He A, Chen X, Tan M, Chen Y, Lu D, Zhang X, et al. Acetyl-CoA derived from hepatic peroxisomal \u03b2-oxidation inhibits autophagy and promotes steatosis via mTORC1 activation. Mol Cell. 2020;79(1):30-42.e4. https:\/\/doi.org\/10.1016\/j.molcel.2020.05.007.","journal-title":"Mol Cell"},{"key":"1417_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2015.00141","volume":"6","author":"S Iezzi","year":"2015","unstructured":"Iezzi S, Fanciulli M. Discovering Che-1\/AATF: a new attractive target for cancer therapy. Front Genet. 2015;6:141. https:\/\/doi.org\/10.3389\/fgene.2015.00141.","journal-title":"Front Genet"},{"issue":"5","key":"1417_CR28","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/cdd.2009.175","volume":"17","author":"S Ishigaki","year":"2010","unstructured":"Ishigaki S, Fonseca SG, Oslowski CM, Jurczyk A, Shearstone JR, Zhu LJ, et al. AATF mediates an antiapoptotic effect of the unfolded protein response through transcriptional regulation of AKT1. Cell Death Differ. 2010;17(5):774\u201386. https:\/\/doi.org\/10.1038\/cdd.2009.175.","journal-title":"Cell Death Differ"},{"issue":"20","key":"1417_CR29","doi-asserted-by":"publisher","first-page":"3951","DOI":"10.1038\/emboj.2012.258","volume":"31","author":"JG Jackson","year":"2012","unstructured":"Jackson JG, Lozano G. Che-ating death: CHE1\/AATF protects from p53-mediated apoptosis. EMBO J. 2012;31(20):3951\u20133. https:\/\/doi.org\/10.1038\/emboj.2012.258.","journal-title":"EMBO J"},{"issue":"1\u20132","key":"1417_CR30","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s11010-006-9317-1","volume":"297","author":"D Kaul","year":"2007","unstructured":"Kaul D, Mehrotra A. Functional characterization of AATF transcriptome in human leukemic cells. Mol Cell Biochem. 2007;297(1\u20132):215\u201320. https:\/\/doi.org\/10.1007\/s11010-006-9317-1.","journal-title":"Mol Cell Biochem"},{"issue":"5","key":"1417_CR31","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.cmet.2015.04.004","volume":"21","author":"C Koliaki","year":"2015","unstructured":"Koliaki C, Szendroedi J, Kaul K, Jelenik T, Nowotny P, Jankowiak F, et al. Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis. Cell Metab. 2015;21(5):739\u201346. https:\/\/doi.org\/10.1016\/j.cmet.2015.04.004.","journal-title":"Cell Metab"},{"issue":"4","key":"1417_CR32","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1002\/hep.30346","volume":"69","author":"DP Kumar","year":"2019","unstructured":"Kumar DP, Santhekadur PK, Seneshaw M, Mirshahi F, Uram-Tuculescu C, Sanyal AJ. A regulatory role of Apoptosis Antagonizing Transcription Factor in the pathogenesis of nonalcoholic fatty liver disease and hepatocellular carcinoma. Hepatology. 2019;69(4):1520\u201334. https:\/\/doi.org\/10.1002\/hep.30346.","journal-title":"Hepatology"},{"issue":"1","key":"1417_CR33","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3390\/metabo12010054","volume":"12","author":"W Li","year":"2022","unstructured":"Li W, Sultana N, Yuan L, Forssell C, Yuan XM. CD74 in apoptotic macrophages is associated with inflammation, plaque progression and clinical manifestations in human atherosclerotic lesions. Metabolites. 2022;12(1):54. https:\/\/doi.org\/10.3390\/metabo12010054.","journal-title":"Metabolites"},{"issue":"1","key":"1417_CR34","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12944-024-02108-x","volume":"23","author":"Y Li","year":"2024","unstructured":"Li Y, Yang P, Ye J, Xu Q, Wu J, Wang Y. Updated mechanisms of MASLD pathogenesis. Lipids Health Dis. 2024;23(1):117. https:\/\/doi.org\/10.1186\/s12944-024-02108-x.","journal-title":"Lipids Health Dis"},{"issue":"8","key":"1417_CR35","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1017\/S1751731116000380","volume":"10","author":"DD Liu","year":"2016","unstructured":"Liu DD, Han CC, Wan HF, He F, Xu HY, Wei SH, et al. Effects of inhibiting PI3K-Akt-mTOR pathway on lipid metabolism homeostasis in goose primary hepatocytes. Animal. 2016;10(8):1319\u201327. https:\/\/doi.org\/10.1017\/S1751731116000380.","journal-title":"Animal"},{"issue":"18","key":"1417_CR36","doi-asserted-by":"publisher","first-page":"3450","DOI":"10.1002\/jssc.202100051","volume":"44","author":"Z Liu","year":"2021","unstructured":"Liu Z, Wang P, Liu Z, Wei C, Li Y, Liu L. Evaluation of liver tissue extraction protocol for untargeted metabolomics analysis by ultra-high-performance liquid chromatography\/tandem mass spectrometry. J Sep Sci. 2021;44(18):3450\u201361. https:\/\/doi.org\/10.1002\/jssc.202100051.","journal-title":"J Sep Sci"},{"issue":"1","key":"1417_CR37","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgast-2019-000341","volume":"7","author":"IV Maev","year":"2020","unstructured":"Maev IV, Samsonov AA, Palgova LK, Pavlov CS, Vovk EI, Shirokova EN, et al. Effectiveness of phosphatidylcholine in alleviating steatosis in patients with non-alcoholic fatty liver disease and cardiometabolic comorbidities (MANPOWER study). BMJ Open Gastroenterol. 2020;7(1):e000341. https:\/\/doi.org\/10.1136\/bmjgast-2019-000341.","journal-title":"BMJ Open Gastroenterol"},{"issue":"5","key":"1417_CR38","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.cellsig.2009.01.004","volume":"21","author":"RM Memmott","year":"2009","unstructured":"Memmott RM, Dennis PA. Akt-dependent and -independent mechanisms of mTOR regulation in cancer. Cell Signal. 2009;21(5):656\u201364. https:\/\/doi.org\/10.1016\/j.cellsig.2009.01.004.","journal-title":"Cell Signal"},{"issue":"3","key":"1417_CR39","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1111\/liv.14309","volume":"40","author":"G Naguib","year":"2020","unstructured":"Naguib G, Morris N, Yang S, Fryzek N, Haynes-Williams V, Huang WA, et al. Dietary fatty acid oxidation is decreased in nonc fatty liver disease: A palmitate breath test study. Liver Int. 2020;40(3):590\u20137. https:\/\/doi.org\/10.1111\/liv.14309.","journal-title":"Liver Int"},{"key":"1417_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.797923","volume":"13","author":"D Osipova","year":"2022","unstructured":"Osipova D, Kokoreva K, Lazebnik L, Golovanova E, Pavlov C, Dukhanin A, et al. Regression of Liver Steatosis Following Phosphatidylcholine Administration: A Review of Molecular and Metabolic Pathways Involved. Front Pharmacol. 2022;13:797923. https:\/\/doi.org\/10.3389\/fphar.2022.797923.","journal-title":"Front Pharmacol"},{"issue":"7503","key":"1417_CR41","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/nature13478","volume":"510","author":"RJ Perry","year":"2014","unstructured":"Perry RJ, Samuel VT, Petersen KF, Shulman GI. The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes. Nature. 2014;510(7503):84\u201391. https:\/\/doi.org\/10.1038\/nature13478.","journal-title":"Nature"},{"issue":"4","key":"1417_CR42","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1097\/MEG.0000000000001033","volume":"30","author":"T Poynard","year":"2018","unstructured":"Poynard T, Munteanu M, Charlotte F, et al. Impact of steatosis and inflammation definitions on the performance of NASH tests. Eur J Gastroenterol Hepatol. 2018;30(4):384\u201391. https:\/\/doi.org\/10.1097\/MEG.0000000000001033.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1417_CR43","doi-asserted-by":"publisher","unstructured":"Prentki M, Madiraju M. Glycerolipid Metabolism and Signaling in Health and Disease. Endocrine Reviews, 2008;29(6) 647\u2013676, https:\/\/doi.org\/10.1210\/er.2008-0007","DOI":"10.1210\/er.2008-0007"},{"key":"1417_CR44","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1002\/hep.21763","volume":"46","author":"P Puri","year":"2007","unstructured":"Puri P, Baillie RA, Wiest MM, Mirshahi F, Choudhury J, Cheung O, et al. A lipidomic analysis of nonalcoholic fatty liver disease. Hepatology. 2007;46:1081\u201390. https:\/\/doi.org\/10.1002\/hep.21763.","journal-title":"Hepatology"},{"key":"1417_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1294267","volume":"10","author":"G Rao","year":"2023","unstructured":"Rao G, Peng X, Li X, An K, He H, Fu X, et al. Unmasking the enigma of lipid metabolism in metabolic dysfunction-associated steatotic liver disease: from mechanism to the clinic. Front Med. 2023;10:1294267. https:\/\/doi.org\/10.3389\/fmed.2023.1294267.","journal-title":"Front Med"},{"issue":"6","key":"1417_CR46","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.jhep.2022.04.002","volume":"76","author":"V Ratziu","year":"2022","unstructured":"Ratziu V, Francque S, Sanyal A. Breakthroughs in therapies for NASH and remaining challenges. J Hepatol. 2022;76(6):1263\u201378. https:\/\/doi.org\/10.1016\/j.jhep.2022.04.002.","journal-title":"J Hepatol"},{"issue":"1","key":"1417_CR47","doi-asserted-by":"publisher","first-page":"6489","DOI":"10.1038\/s41598-020-63579-3","volume":"10","author":"M R\u00e9gnier","year":"2020","unstructured":"R\u00e9gnier M, Polizzi A, Smati S, Lukowicz C, Fougerat A, Lippi Y, et al. Hepatocyte-specific deletion of Ppar\u03b1 promotes NAFLD in the context of obesity. Sci Rep. 2020;10(1):6489. https:\/\/doi.org\/10.1038\/s41598-020-63579-3.","journal-title":"Sci Rep"},{"issue":"5","key":"1417_CR48","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","volume":"77","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Neuschwander-Tetri BA, Siddiqui MS, Abdelmalek MF, Caldwell S, Barb D, et al. Aasld practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology. 2023;77(5):1797\u2013835. https:\/\/doi.org\/10.1097\/HEP.0000000000000323.","journal-title":"Hepatology"},{"issue":"2","key":"1417_CR49","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.135626","volume":"6","author":"ES Selen","year":"2021","unstructured":"Selen ES, Choi J, Wolfgang MJ. Discordant hepatic fatty acid oxidation and triglyceride hydrolysis leads to liver disease. JCI Insight. 2021;6(2):e135626. https:\/\/doi.org\/10.1172\/jci.insight.135626.","journal-title":"JCI Insight"},{"issue":"12","key":"1417_CR50","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s11745-010-3488-y","volume":"45","author":"GA Soliman","year":"2010","unstructured":"Soliman GA, Acosta-Jaquez HA, Fingar DC. mTORC1 inhibition via rapamycin promotes triacylglycerol lipolysis and release of free fatty acids in 3T3-L1 adipocytes. Lipids. 2010;45(12):1089\u2013100. https:\/\/doi.org\/10.1007\/s11745-010-3488-y.","journal-title":"Lipids"},{"issue":"5","key":"1417_CR51","doi-asserted-by":"publisher","first-page":"3383","DOI":"10.1002\/jcp.30141","volume":"236","author":"AN Srinivas","year":"2021","unstructured":"Srinivas AN, Suresh D, Mirshahi F, Santhekadur PK, Sanyal AJ, Kumar DP. Emerging roles of AATF: Checkpoint signaling and beyond. J Cell Physiol. 2021;236(5):3383\u201395. https:\/\/doi.org\/10.1002\/jcp.30141.","journal-title":"J Cell Physiol"},{"issue":"1","key":"1417_CR52","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/jcp.31151","volume":"239","author":"AN Srinivas","year":"2024","unstructured":"Srinivas AN, Suresh D, Chidambaram SB, Santhekadur PK, Kumar DP. Apoptosis antagonizing transcription factor-mediated liver damage and inflammation to cancer: therapeutic intervention by curcumin in experimental metabolic dysfunction associated steatohepatitis-hepatocellular carcinoma. J Cell Physiol. 2024a;239(1):135\u201351. https:\/\/doi.org\/10.1002\/jcp.31151.","journal-title":"J Cell Physiol"},{"key":"1417_CR53","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.13646","author":"AN Srinivas","year":"2024","unstructured":"Srinivas AN, Suresh D, Vishwanath PM, Satish S, Santhekadur PK, Koka S, et al. TACE inhibition: a promising therapeutic intervention against AATF-mediated steatohepatitis to hepatocarcinogenesis. Mol Oncol. 2024b. https:\/\/doi.org\/10.1002\/1878-0261.13646.","journal-title":"Mol Oncol"},{"key":"1417_CR54","doi-asserted-by":"publisher","unstructured":"Srinivas AN, Suresh D, Suvarna D, Pathak P, Giri S, Suman, et al. Unraveling the Potential Role of Tecomella undulata in Experimental NASH. Int J Mol Sci. 2023;24(4):3244. https:\/\/doi.org\/10.3390\/ijms24043244.","DOI":"10.3390\/ijms24043244"},{"issue":"2","key":"1417_CR55","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/S2213-8587(24)00318-8","volume":"13","author":"N Stefan","year":"2025","unstructured":"Stefan N, Yki-J\u00e4rvinen H, Neuschwander-Tetri BA. Metabolic dysfunction-associated steatotic liver disease: heterogeneous pathomechanisms and effectiveness of metabolism-based treatment. Lancet Diabetes Endocrinol. 2025;13(2):134\u201348. https:\/\/doi.org\/10.1016\/S2213-8587(24)00318-8.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1417_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.601710","volume":"10","author":"D Suresh","year":"2020","unstructured":"Suresh D, Srinivas AN, Kumar DP. Etiology of hepatocellular carcinoma: special focus on fatty liver disease. Front Oncol. 2020;10:601710. https:\/\/doi.org\/10.3389\/fonc.2020.601710.","journal-title":"Front Oncol"},{"key":"1417_CR57","doi-asserted-by":"publisher","first-page":"1130380","DOI":"10.3389\/fonc.2023.1130380","volume":"13","author":"D Suresh","year":"2023","unstructured":"Suresh D, Srinivas AN, Prashant A, Satish S, Vishwanath P, Nataraj SM, et al. AATF inhibition exerts antiangiogenic effects against human hepatocellular carcinoma. Front Oncol. 2023;13:1130380. https:\/\/doi.org\/10.3389\/fonc.2023.1130380.","journal-title":"Front Oncol"},{"issue":"9","key":"1417_CR58","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41575-021-00448-y","volume":"18","author":"G Targher","year":"2021","unstructured":"Targher G, Corey KE, Byrne CD, Roden M. The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments. Nat Rev Gastroenterol Hepatol. 2021;18(9):599\u2013612. https:\/\/doi.org\/10.1038\/s41575-021-00448-y.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"12","key":"1417_CR59","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1016\/j.ajpath.2023.08.007","volume":"193","author":"N Venkatesan","year":"2023","unstructured":"Venkatesan N, Doskey LC, Malhi H. The role of endoplasmic reticulum in lipotoxicity during metabolic dysfunction-associated steatotic liver disease (MASLD) pathogenesis. Am J Pathol. 2023;193(12):1887\u201399. https:\/\/doi.org\/10.1016\/j.ajpath.2023.08.007.","journal-title":"Am J Pathol"},{"issue":"4","key":"1417_CR60","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.cell.2011.09.045","volume":"147","author":"AK Walker","year":"2011","unstructured":"Walker AK, Jacobs RL, Watts JL, Rottiers V, Jiang K, Finnegan DM, et al. A conserved SREBP-1\/phosphatidylcholine feedback circuit regulates lipogenesis in metazoans. Cell. 2011;147(4):840\u201352. https:\/\/doi.org\/10.1016\/j.cell.2011.09.045.","journal-title":"Cell"},{"issue":"11","key":"1417_CR61","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1038\/s41388-017-0054-6","volume":"37","author":"D Welcker","year":"2018","unstructured":"Welcker D, Jain M, Khurshid S, Joki\u0107 M, H\u00f6hne M, Schmitt A, et al. AATF suppresses apoptosis, promotes proliferation and is critical for Kras-driven lung cancer. Oncogene. 2018;37(11):1503\u201318. https:\/\/doi.org\/10.1038\/s41388-017-0054-6.","journal-title":"Oncogene"},{"issue":"1","key":"1417_CR62","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3892\/ol.2013.1336","volume":"6","author":"L Yang","year":"2013","unstructured":"Yang L, Yuan J, Liu L, Shi C, Wang L, Tian F, et al. \u0391-linolenic acid inhibits human renal cell carcinoma cell proliferation through PPAR-\u03b3 activation and COX-2 inhibition. Oncol Lett. 2013;6(1):197\u2013202. https:\/\/doi.org\/10.3892\/ol.2013.1336.","journal-title":"Oncol Lett"},{"issue":"4","key":"1417_CR63","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","volume":"77","author":"ZM Younossi","year":"2023","unstructured":"Younossi ZM, Golabi P, Paik JM, Henry A, Van Dongen C, Henry L. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology. 2023;77(4):1335\u201347. https:\/\/doi.org\/10.1097\/HEP.0000000000000004.","journal-title":"Hepatology"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10020-025-01417-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-025-01417-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-025-01417-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T14:05:57Z","timestamp":1770645957000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s10020-025-01417-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,13]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1417"],"URL":"https:\/\/doi.org\/10.1186\/s10020-025-01417-w","relation":{},"ISSN":["1528-3658"],"issn-type":[{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,13]]},"assertion":[{"value":"28 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19"}}